Chronic nicotine improves short-term memory selectively in a G72 mouse model of schizophrenia

British Journal of Pharmacology

Volumn 171, Issue 7, 2014, Pages 1758-1771

  Hambsch, B ^a   Keyworth, H ^b   Lind, J ^b   Otte, D M ^a   Racz, I ^a   Kitchen, I ^b   Bailey, A ^b   Zimmer, A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF SURREY   (United Kingdom)

Author keywords

chronic nicotine; cognition; G72 mouse model; G72 G30 gene locus; nicotinic acetylcholine receptor; receptor autoradiography; schizophrenia; self medication; short term memory; susceptibility gene

Indexed keywords

NICOTINE; RECEPTOR SUBTYPE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; BRAIN REGION; COGNITIVE DEFECT; CONDITIONED PLACE PREFERENCE TEST; CONTROLLED STUDY; EXPERIMENTAL BEHAVIORAL TEST; FOREBRAIN; GAS CHROMATOGRAPHY; GENETIC SUSCEPTIBILITY; GENOTYPE; HIPPOCAMPUS; INSTRUMENTAL CONDITIONING; MASS SPECTROMETRY; MORRIS WATER MAZE TEST; MOUSE; NONHUMAN; OSMOTIC MINIPUMP; PREPULSE INHIBITION; PREVALENCE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHIZOPHRENIA; SELF MEDICATION; SHORT TERM MEMORY; SMOKING; SPATIAL LEARNING; STATE DEPENDENT LEARNING; SYMPTOMATOLOGY; TASK PERFORMANCE; TRANSGENIC MOUSE; UPREGULATION; WILD TYPE; WORKING MEMORY;

CHRONIC NICOTINE; COGNITION; G72 MOUSE MODEL; G72/G30 GENE LOCUS; NICOTINIC ACETYLCHOLINE RECEPTOR; RECEPTOR AUTORADIOGRAPHY; SCHIZOPHRENIA; SELF-MEDICATION; SHORT-TERM MEMORY; SUSCEPTIBILITY GENE;

ALPHA7 NICOTINIC ACETYLCHOLINE RECEPTOR; ANIMALS; BEHAVIOR, ANIMAL; CARRIER PROTEINS; COGNITION; DISEASE MODELS, ANIMAL; DRUG ADMINISTRATION SCHEDULE; GENOTYPE; HUMANS; MEMORY, SHORT-TERM; MICE; MICE, TRANSGENIC; NEURAL INHIBITION; NICOTINE; NICOTINIC AGONISTS; NOOTROPIC AGENTS; PHENOTYPE; PROSENCEPHALON; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIAL BEHAVIOR; TIME FACTORS;

EID: 84908884043     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/bph.12578     Document Type: Article

References (56)

1. Adler LE, Olincyn A, Waldo M, Harris JQ, Qriffith J, Stevens K, et al. (1998). Schizophrenia, sensory gating, and nicotinic receptors. Schizophr Bull 24: 189-202.
2. Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Catterall WA, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013a). The Concise Guide to PHARMACOLOGY 2013/14: Overview. Br J Pharmacol 170: 1449-1867.
3. Alexander SP, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, Peters JA, Harmar AJ, and CGTP Collaborators (2013b). The Concise Guide to PHARMACOLOGY 2013/14: Ligand-Gated Ion Channels. Br J Pharmacol 170: 1582-1606.
4. AlSharari SD, Akbarali HI, Abdullah RA, Shahab O, Auttachoat W, Ferreira GA, et al. (2013). Novel insights on the effect of nicotine in a murine colitis model. J Pharmacol Exp Ther 344: 207-217.
5. Besson M, Granon S, Mameli-Engvall M, Cloez-Tayarani I, Maubourguet N, Cormier A, et al. (2007). Long-term effects of chronic nicotine exposure on brain nicotinic receptors. Proc Natl Acad Sci U S A 104: 8155-8160.
6. Bird CM, Burgess N, (2008). The hippocampus and memory: insights from spatial processing. Nat Rev Neurosci 9: 182-194.
7. Brambilla P, Cerruti S, Bellani M, Perlini C, Ferro A, Marinelli V, et al. (2011). Shared impairment in associative learning in schizophrenia and bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry 35: 1093-1099.
8. Chen YJ, Johnson MA, Lieberman MD, Goodchild RE, Schobel S, Lewandowski N, et al. (2008). Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. J Neurosci 28: 6872-6883.
9. Cheng L, Hattori E, Nakajima A, Woehrle NS, Opal MD, Zhang C, et al. (2014). Expression of the G72/G30 gene in transgenic mice induces behavioral changes. Mol Psychiatry 19: 175-183.
10. Chowdhury P, (1990). Endocrine and metabolic regulation of body mass by nicotine: role of growth hormone. Ann Clin Lab Sci 20: 415-419.
11. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, et al. (2002). Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A 99: 13675-13680.
12. Dajas-Bailador F, Wonnacott S, (2004). Nicotinic acetylcholine receptors and the regulation of neuronal signalling. Trends Pharmacol Sci 25: 317-324.
13. Dépatie L, O'Driscoll GA, Holahan AL, Atkinson V, Thavundayil JX, Kin NN, et al. (2002). Nicotine and behavioral markers of risk for schizophrenia: a double-blind, placebo-controlled, cross-over study. Neuropsychopharmacology 27: 1056-1070.
14. De Leon J, Diaz FJ, (2005). A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res 76: 135-157.
15. Derntl B, Habel U, (2011). Deficits in social cognition: a marker for psychiatric disorders? Eur Arch Psychiatry Clin Neurosci 261 (Suppl. 2): S145-S149.
16. Detera-Wadleigh SD, McMahon FJ, (2006). G72/G30 in schizophrenia and bipolar disorder: review and meta-analysis. Biol Psychiatry 60: 106-114.
17. Doura MB, Gold AB, Keller AB, Perry DC, (2008). Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure. Brain Res 1215: 40-52.
18. Drews E, Otte DM, Zimmer A, (2013). Involvement of the primate specific gene G72 in schizophrenia: from genetic studies to pathomechanisms. Neurosci Biobehav Rev 37: 2410-2417.
19. Fabian-Fine R, Skehel P, Errington ML, Davies HA, Sher E, Stewart MG, et al. (2001). Ultrastructural distribution of the alpha7 nicotinic acetylcholine receptor subunit in rat hippocampus. J Neurosci 21: 7993-8003.
20. Florescu A, Ferrence R, Einarson T, Selby P, Soldin O, Koren G, (2009). Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: focus on developmental toxicology. Ther Drug Monit 31: 14-30.
21. Gehring WJ, Taylor SF, (2004). When the going gets tough, the cingulate gets going. Nat Neurosci 7: 1285-1287.
22. George TP, Termine A, Sacco KA, Allen TM, Reutenauer E, Vessicchio JC, et al. (2006). A preliminary study of the effects of cigarette smoking on prepulse inhibition in schizophrenia: involvement of nicotinic receptor mechanisms. Schizophr Res 87: 307-315.
23. Gold JM, Fuller RL, Robinson BM, McMahon RP, Braun EL, Luck SJ, (2006). Intact attentional control of working memory encoding in schizophrenia. J Abnorm Psychol 115: 658-673.
24. Harris JG, Kongs S, Allensworth D, Martin L, Tregellas J, Sullivan B, et al. (2004). Effects of nicotine on cognitive deficits in schizophrenia. Neuropsychopharmacology 29: 1378-1385.
25. Hauser TA, Kucinski A, Jordan KG, Gatto GJ, Wersinger SR, Hesse RA, et al. (2009). TC-5619: an alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia. Biochem Pharmacol 78: 803-812.
26. Ison JR, Allen PD, (2007). Pre- but not post-menopausal female CBA/CaJ mice show less prepulse inhibition than male mice of the same age. Behav Brain Res 185: 76-81.
27. Kilkenny C, Browne W, Cuthill IC, Emerson M, Altman DG, (2010). Animal research: reporting in vivo experiments: the ARRIVE guidelines. Br J Pharmacol 160: 1577-1579.
28. Korostishevsky M, Kaganovich M, Cholostoy A, Ashkenazi M, Ratner Y, Dahary D, et al. (2004). Is the G72/G30 locus associated with schizophrenia? single nucleotide polymorphisms, haplotypes, and gene expression analysis. Biol Psychiatry 56: 169-176.
29. Kumari V, Postma P, (2005). Nicotine use in schizophrenia: the self medication hypotheses. Neurosci Biobehav Rev 29: 1021-1034.
30. Kvajo M, Dhilla A, Swor DE, Karayiorgou M, Gogos JA, (2008). Evidence implicating the candidate schizophrenia/bipolar disorder susceptibility gene G72 in mitochondrial function. Mol Psychiatry 13: 685-696.
31. Lee I, Kesner RP, (2004). Encoding versus retrieval of spatial memory: double dissociation between the dentate gyrus and the perforant path inputs into CA3 in the dorsal hippocampus. Hippocampus 14: 66-76.
32. Leonard S, Freedman R, (2006). Genetics of chromosome 15q13-q14 in schizophrenia. Biol Psychiatry 60: 115-122.
33. Levin ED, (2012). α7-Nicotinic receptors and cognition. Curr Drug Targets 13: 602-606.
34. Levin ED, Wilson W, Rose JE, McEvoy J, (1996). Nicotine-haloperidol interactions and cognitive performance in schizophrenics. Neuropsychopharmacology 15: 429-436.
35. McGrath J, Drummond G, McLachlan E, Kilkenny C, Wainwright C, (2010). Guidelines for reporting experiments involving animals: the ARRIVE guidelines. Br J Pharmacol 160: 1573-1576.
36. Marks MJ, Whiteaker P, Grady SR, Picciotto MR, McIntosh JM, Collins AC, (2002). Characterization of [(125) I]epibatidine binding and nicotinic agonist-mediated (86) Rb(+) efflux in interpeduncular nucleus and inferior colliculus of beta2 null mutant mice. J Neurochem 81: 1102-1115.
37. Marks MJ, Rowell PP, Cao J-Z, Grady SR, McCallum SE, Collins AC, (2004). Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment. Neuropharmacology 46: 1141-1157.
38. Massadeh AD, Gharaibeh AA, Omari KW, (2009). A single-step extraction method for the determination of nicotine and cotinine in Jordanian smokers' blood and urine samples by RP-HPLC and GC-MS. J Chromatogr Sci 47: 170-177.
39. Metaxas A, Bailey A, Barbano MF, Galeote L, Maldonado R, Kitchen I, (2010). Differential region-specific regulation of alpha4beta2∗ nAChRs by self-administered and non-contingent nicotine in c57bl/6j mice. Addict Biol 15: 464-479.
40. Metaxas A, Keyworth H, Yoo J, Chen Y, Kitchen I, Bailey A, (2012). The stereotypy-inducing and OCD-like effects of chronic 'binge' cocaine are modulated by distinct subtypes of nicotinic acetylcholine receptors. Br J Pharmacol 167: 450-464.
41. Metaxas A, Al-Hasani R, Farshim P, Tubby K, Berwick A, Ledent C, et al. (2013). Genetic deletion of the adenosine A receptor prevents nicotine-induced upregulation of alpha7, but not alpha4beta2∗ nicotinic acetylcholine receptor binding in the brain. Neuropharmacology 71: 228-236.
42. Mexal S, Berger R, Logel J, Ross RG, Freedman R, Leonard S, (2010). Differential regulation of α7 nicotinic receptor gene (CHRNA7) expression in schizophrenic smokers. J Mol Neurosci 40: 185-195.
43. Moragrega I, Carrasco MC, Vicens P, Redolat R, (2003). Spatial learning in male mice with different levels of aggressiveness: effects of housing conditions and nicotine administration. Behav Brain Res 147: 1-8.
44. Myers CS, Robles O, Kakoyannis AN, Sherr JD, Avila MT, Blaxton TA, et al. (2004). Nicotine improves delayed recognition in schizophrenic patients. Psychopharmacology (Berl) 174: 334-340.
45. Nuechterlein KH, Green MF, Kern RS, Baade LE, Barch DM, Cohen JD, et al. (2008). The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity. Am J Psychiatry 165: 203-213.
46. Orr-Urtreger A, Goldner FM, Saeki M, Lorenzo I, Goldberg L, De Biasi M, et al. (1997). Mice deficient in the alpha7 neuronal nicotinic acetylcholine receptor lack alpha-bungarotoxin binding sites and hippocampal fast nicotinic currents. J Neurosci 17: 9165-9171.
47. Otte DM, Bilkei-Gorzõ A, Filiou MD, Turck CW, Yilmaz O, Holst MI, et al. (2009). Behavioral changes in G72/G30 transgenic mice. Eur Neuropsychopharmacol 19: 339-348.
48. Otte DM, Sommersberg B, Kudin A, Guerrero C, Albayram O, Filiou MD, et al. (2011). N-acetyl cysteine treatment rescues cognitive deficits induced by mitochondrial dysfunction in G72/G30 transgenic mice. Neuropsychopharmacology 36: 2233-2243.
49. Sabia S, Elbaz A, Dugravot A, Head J, Shipley M, Hagger-Johnson G, et al. (2012). Impact of smoking on cognitive decline in early old age: the Whitehall II cohort study. Arch Gen Psychiatry 69: 627-635.
50. Sanderson DJ, Bannerman DM, (2012). The role of habituation in hippocampus-dependent spatial working memory tasks: evidence from GluA1 AMPA receptor subunit knockout mice. Hippocampus 22: 981-994.
51. Shin HS, Kim JG, Shin YJ, Jee SH, (2002). Sensitive and simple method for the determination of nicotine and cotinine in human urine, plasma and saliva by gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 769: 177-183.
52. Smieskova R, Fusar-Poli P, Allen P, Bendfeldt K, Stieglitz RD, Drewe J, et al. (2010). Neuroimaging predictors of transition to psychosis- a systematic review and meta-analysis. Neurosci Biobehav Rev 34: 1207-1222.
53. Smith RC, Infante M, Ali A, Nigam S, Kotsaftis A, (2001). Effects of cigarette smoking on psychopathology scores in patients with schizophrenia: an experimental study. Subst Abus 22: 175-186.
54. Timofeeva OA, Levin ED, (2011). Glutamate and nicotinic receptor interactions in working memory: importance for the cognitive impairment of schizophrenia. Neuroscience 195: 21-36.
55. Whiteaker P, Jimenez M, McIntosh JM, Collins AC, Marks MJ, (2000). Identification of a novel nicotinic binding site in mouse brain using [(125)I]-epibatidine. Br J Pharmacol 131: 729-739.
56. Ziedonis D, Hitsman B, Beckham JC, Zvolensky M, Adler LE, Audrain-McGovern J, et al. (2008). Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res 10: 1691-1715.